https://www.selleckchem.com/pr....oducts/fluorescein-5
The incidences of SN, neutropenic fever and neutropenia were not different between groups. Patients with a lower baseline ANC and white ethnicity were at a higher risk for SN. AC (doxorubicin and cyclophosphamide) was the most commonly used chemotherapy regimen (38% of total cycles). There was no difference in the efficacy of the OBI and TI methods for preventing SN, neutropenic fever and neutropenia. There was no difference in the efficacy of the OBI and TI methods for preventing SN, neutropenic fever and neut
Like
Comment
Share
